Pancreatic cancer cell–derived exosomal microRNA‐27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2

Pancreatic cancer (PC) remains a primary cause of cancer‐related deaths worldwide. Existing literature has highlighted the oncogenic role of microRNA‐27a (miR‐27a) in multiple cancers. Hence, the current study aimed to clarify the potential therapeutic role of PC cell–derived exosomal miR‐27a in human microvascular endothelial cell (HMVEC) angiogenesis in PC. Initially, differentially expressed genes (DEGs) and miRs related to PC were identified by microarray analysis. Microarray analysis provided data predicting the interaction between miR‐27a and BTG2 in PC, which was further verified by the elevation or depletion of miR‐27a. Next, the expression of miR‐27a and BTG2 in the PC tissues was quantified. HMVECs were exposed to exosomes derived from PC cell line PANC‐1 to investigate the effects associated with PC cell–derived exosomes carrying miR‐27a on HMVEC proliferation, invasion and angiogenesis. Finally, the effect of miR‐27a on tumorigenesis and microvessel density (MVD) was analysed after xenograft tumour inoculation in nude mice. Our results revealed that miR‐27a was highly expressed, while BTG2 was poorly expressed in both PC tissues and cell lines. miR‐27a targeted BTG2. Moreover, miR‐27a silencing inhibited PC cell proliferation and invasion, and promoted apoptosis through the elevation of BTG2. The in vitro assays revealed that PC cell–derived exosomes carrying miR‐27a stimulated HMVEC proliferation, invasion and angiogenesis, while this effect was reversed in the HMVECs cultured with medium containing GW4869‐treated PANC‐1 cells. Furthermore, in vivo experiment revealed that miR‐27a knockdown suppressed tumorigenesis and MVD. Taken together, cell‐derived exosomes carrying miR‐27a promotes HMVEC angiogenesis via BTG2 in PC.

[1]  S. Monzen,et al.  Exosomes released from pancreatic cancer cells enhance angiogenic activities via dynamin-dependent endocytosis in endothelial cells in vitro , 2018, Scientific Reports.

[2]  Bo Chen,et al.  Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo‐YAP signaling , 2018, Journal of cellular physiology.

[3]  T. Okumura,et al.  An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker , 2018, BMC Cancer.

[4]  Jin-hai Tang,et al.  Exosomal MicroRNA MiR-1246 Promotes Cell Proliferation, Invasion and Drug Resistance by Targeting CCNG2 in Breast Cancer , 2017, Cellular Physiology and Biochemistry.

[5]  D. Gozal,et al.  Exosomes contribute to endothelial integrity and acute chest syndrome risk: Preliminary findings , 2017, Pediatric pulmonology.

[6]  R. Postier,et al.  Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer , 2017, Oncotarget.

[7]  Y. Tu,et al.  MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β-catenin signaling pathway. , 2017, Oncology reports.

[8]  M. Fabbri,et al.  Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic Applications , 2017, Cancers.

[9]  S. Fan,et al.  Exosomes containing differential expression of microRNA and mRNA in osteosarcoma that can predict response to chemotherapy , 2017, Oncotarget.

[10]  S. Fan,et al.  Exosomes containing differential expression of microRNA and mRNA in osteosarcoma that can predict response to chemotherapy , 2017, Oncotarget.

[11]  Raghu Kalluri,et al.  Exosomes Facilitate Therapeutic Targeting of Oncogenic Kras in Pancreatic Cancer , 2017, Nature.

[12]  H. Cai,et al.  Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma , 2017, Oncogene.

[13]  Duo Zhang,et al.  Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo. , 2017, American journal of physiology. Lung cellular and molecular physiology.

[14]  X. Man,et al.  Toll-like receptor 4 promotes angiogenesis in pancreatic cancer via PI3K/AKT signaling. , 2016, Experimental cell research.

[15]  H. Abrahamse,et al.  The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro. , 2016, Journal of photochemistry and photobiology. B, Biology.

[16]  Jianwen Liu,et al.  MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2 , 2016, Oncotarget.

[17]  A. Mansour,et al.  Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents , 2016, Scientific Reports.

[18]  Yiwei Li,et al.  MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer , 2016, International journal of biological sciences.

[19]  A. Saftoiu,et al.  VEGF expression in pancreatic cancer and other malignancies: a review of the literature , 2015, Romanian journal of internal medicine = Revue roumaine de medecine interne.

[20]  Jian Chen,et al.  Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p , 2015, Oncotarget.

[21]  He Xiao,et al.  MicroRNA-21 regulates the expression of BTG2 in HepG2 liver cancer cells , 2015, Molecular medicine reports.

[22]  Zhiwei Wang,et al.  Genistein inhibits cell growth and invasion through regulation of miR-27a in pancreatic cancer cells. , 2014, Current pharmaceutical design.

[23]  Shu-yun Shi,et al.  Shikonin promotes autophagy in BXPC-3 human pancreatic cancer cells through the PI3K/Akt signaling pathway , 2014, Oncology letters.

[24]  F. Yu,et al.  miR-27a regulates endothelial differentiation of breast cancer stem like cells , 2014, Oncogene.

[25]  Zhenghui Xiong,et al.  MicroRNA-29a upregulates MMP2 in oral squamous cell carcinoma to promote cancer invasion and anti-apoptosis. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[26]  E. Giovannetti,et al.  MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression. , 2014, Gastroenterology.

[27]  M. Zöller.  Pancreatic cancer diagnosis by free and exosomal miRNA. , 2013, World journal of gastrointestinal pathophysiology.

[28]  Ri-sheng Que,et al.  Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma , 2013, World Journal of Surgical Oncology.

[29]  Olivier Elemento,et al.  Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration. , 2013, Developmental cell.

[30]  F. Motoi,et al.  miR‐197 induces epithelial–mesenchymal transition in pancreatic cancer cells by targeting p120 catenin , 2013, Journal of cellular physiology.

[31]  Xiaofei Chen,et al.  SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines , 2013, Molecular Biology Reports.

[32]  J. Li,et al.  BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells , 2013, Tumor Biology.

[33]  G. Lin,et al.  Effects of EdU labeling on mesenchymal stem cells. , 2013, Cytotherapy.

[34]  Y. Choi,et al.  BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria , 2012, Clinical & Experimental Metastasis.

[35]  X. Dai,et al.  Involvement of COX-2/PGE2 Pathway in the Upregulation of MMP-9 Expression in Pancreatic Cancer , 2011, Gastroenterology research and practice.

[36]  Zhaohui Lu,et al.  miR-27a regulates the growth, colony formation and migration of pancreatic cancer cells by targeting Sprouty2. , 2010, Cancer letters.

[37]  M. Konopleva,et al.  Methyl 2-Cyano-3,12-dioxooleana-1,9-dien-28-oate Decreases Specificity Protein Transcription Factors and Inhibits Pancreatic Tumor Growth: Role of MicroRNA-27a , 2010, Molecular Pharmacology.

[38]  I. Brandslund,et al.  Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer , 2010, Virchows Archiv.

[39]  Masahiro Yoshida,et al.  Analysis of microvessels in pancreatic cancer: by light microscopy, confocal laser scan microscopy, and electron microscopy. , 2008, Journal of hepato-biliary-pancreatic surgery.

[40]  S. Störkel,et al.  Immunohistochemical Detection of EGFR in Paraffin-embedded Tumor Tissues , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[41]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[42]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.